74 related articles for article (PubMed ID: 22204157)
1. Using online surveillance to monitor EPO dosing.
Fast S; Jobalia A; Ordway F; Luo F
Nephrol News Issues; 2011 Nov; 25(12):24-5. PubMed ID: 22204157
[No Abstract] [Full Text] [Related]
2. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].
Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC
Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189
[TBL] [Abstract][Full Text] [Related]
3. Continuous quality improvement (CQI) in rhu-Epo management: the outcome.
Descamps C; Van Waeleghem JP; Ysebaert D
EDTNA ERCA J; 1996; 22(3):22-6. PubMed ID: 10723328
[TBL] [Abstract][Full Text] [Related]
4. Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients?
Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
Nephrology (Carlton); 2006 Oct; 11(5):394-9. PubMed ID: 17014551
[TBL] [Abstract][Full Text] [Related]
5. [Effect of recombinant human erythropoietin (rHu-EPO) on anemia and selected biochemical parameters in patients in the pre-dialysis period].
Sułowicz W; Drozdz M; Hanicki Z; Kraśniak A; Kuźniewski M
Przegl Lek; 1992; 49(1-2):50-3. PubMed ID: 1455007
[TBL] [Abstract][Full Text] [Related]
6. The EPO/iron marriage: counseling needed.
Bralow S
Nephrol News Issues; 2007 Jun; 21(7):53, 55. PubMed ID: 17623987
[No Abstract] [Full Text] [Related]
7. [Erythropoietin in renal anemia].
Peña Amaro MP; García López J; Camacho Romera M
Rev Enferm; 1992 Mar; 15(163):67-70. PubMed ID: 1565973
[No Abstract] [Full Text] [Related]
8. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
10. [Optimal therapy with erythropoietin (EPO) in patients with renal anemia on hemodialysis therapy].
Merta M; Sobotová D; Zahálková J; Bitterová Z; Jirka T; Knetl P; Kopenec J; Suchanová J; Vlasák J
Sb Lek; 2001; 102(1):41-52. PubMed ID: 11830918
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin. A new frontier.
Rutherford C
J Intraven Nurs; 1991; 14(3):163-5. PubMed ID: 2033478
[TBL] [Abstract][Full Text] [Related]
12. Hemoglobin levels, quality of life, and survival.
Sadler JH; Meyer KB
Nephrol News Issues; 2007 Aug; 21(9):42-3. PubMed ID: 17722853
[No Abstract] [Full Text] [Related]
13. Increased erythropoietin requirements in patients with failed renal transplants returning to a dialysis programme.
Almond MK; Tailor D; Marsh FP; Raftery MJ; Cunningham J
Nephrol Dial Transplant; 1994; 9(3):270-3. PubMed ID: 8052433
[TBL] [Abstract][Full Text] [Related]
14. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous erythropoietin in the treatment of renal anaemia.
Drinovec J; Varl J
Przegl Lek; 1992; 49(1-2):38-40. PubMed ID: 1455004
[TBL] [Abstract][Full Text] [Related]
16. [The effect of correcting anemia with recombinant erythropoietin on the central hemodynamic indices of patients on regular hemodialysis].
Ermolenko VM; Khvoĭnitskiĭ VA; Suprun EK; Tsukerman LI; Pokrovskiĭ IuA
Ter Arkh; 1992; 64(7):86-8. PubMed ID: 1440377
[No Abstract] [Full Text] [Related]
17. ESA therapy for anemia management: a call for civil discourse.
McAllister CJ
Nephrol News Issues; 2007 Jun; 21(7):49-50. PubMed ID: 17623986
[No Abstract] [Full Text] [Related]
18. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].
Fernández-Gallego J; Gutiérrez C
Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885
[No Abstract] [Full Text] [Related]
19. [Erythropoietin: from established therapeutic procedures in renal anemia to future areas of use].
Marsen TA; Pollok M; Baldamus CA
Med Klin (Munich); 1992 Apr; 87(4):207-14. PubMed ID: 1579099
[No Abstract] [Full Text] [Related]
20. Erythropoietin use in peritoneal dialysis patients.
Zimmerman SW; Johnson CA
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):38-41. PubMed ID: 1928078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
